Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report 2026

Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report 2026
Global Outlook – By Type (Contains Antibiotics, Antibiotic-Free), By Application (Drug Discovery, Stem Cell Technologies, Regenerative Medicine And Tissue Engineering, Bio-Pharmaceuticals, Cancer Research, Other Applications), By End-User (Research Laboratories, Academic Institutes, Biotechnology And Pharmaceutical Sector, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Overview
• Ready-To-Use Luria-Bertani (LB) Liquid Medium market size has reached to $11.21 billion in 2025 • Expected to grow to $16.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Surge In R&D Activities Driving Growth In The Ready-To-Use LB Liquid Medium Market • Market Trend: Advancements in Drug Discovery Software • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Ready-To-Use Luria-Bertani (LB) Liquid Medium Market?
Ready-to-use Luria-Bertani (LB) liquid medium is a pre-mixed, nutrient-rich solution for growing various bacterial species. It includes tryptone, yeast extract, and sodium chloride, and requires no additional preparation or sterilization. This medium supports bacterial growth and maintenance in labs, offering a convenient, time-saving solution that ensures consistent results in experiments. The main types of ready-to-use Luria-Bertani (LB) liquid medium are those that contain antibiotics and are antibiotic-free. Ready-to-use LB (Luria-Bertani) liquid mediums include Luria-Bertani (LB) liquid mediums that are formulated with antibiotics to inhibit the growth of unwanted microorganisms, ensuring that only the desired bacteria thrive. They are used for several applications, including drug discovery, stem cell technologies, regenerative medicine and tissue engineering, bio-pharmaceuticals, cancer research, and others, and are used by various end-users, such as research laboratories, academic institutes, the biotechnology and pharmaceutical sectors, and others.
What Is The Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Size and Share 2026?
The ready-to-use luria-bertani (lb) liquid medium market size has grown strongly in recent years. It will grow from $11.21 billion in 2025 to $12.16 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to expansion of microbiology research laboratories, growth in academic life sciences programs, increasing use of bacterial cultures in research, availability of standardized lab consumables, rising demand for reproducible experiments.What Is The Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Growth Forecast?
The ready-to-use luria-bertani (lb) liquid medium market size is expected to see strong growth in the next few years. It will grow to $16.63 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing adoption of automated microbiology workflows, rising demand from biopharmaceutical research, expansion of synthetic biology applications, growing focus on contamination-free media, increasing outsourcing of laboratory research. Major trends in the forecast period include increasing adoption of ready-to-use culture media, rising demand for consistent microbial growth solutions, growing use in high-throughput laboratories, expansion of pre-sterilized media products, enhanced focus on time-efficient lab workflows.Global Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Segmentation
1) By Type: Contains Antibiotics, Antibiotic-Free 2) By Application: Drug Discovery, Stem Cell Technologies, Regenerative Medicine And Tissue Engineering, Bio-Pharmaceuticals, Cancer Research, Other Applications 3) By End-User: Research Laboratories, Academic Institutes, Biotechnology And Pharmaceutical Sector, Other End-Users Subsegments: 1) By Contains Antibiotics: LB Medium With Ampicillin, LB Medium With Kanamycin, LB Medium With Tetracycline, LB Medium With Chloramphenicol, LB Medium With Streptomycin 2) By Antibiotic Free: Standard LB Liquid Medium, LB Liquid Medium With Supplementary Nutrients, LB Liquid Medium For Fast-Growing Bacteria, LB Liquid Medium For Low-Temperature GrowthWhat Are The Drivers Of The Ready-To-Use Luria-Bertani (LB) Liquid Medium Market?
The increasing research and development activities are expected to propel the growth of the ready-to-use Luria-Bertani (LB) liquid medium market going forward. Research and development activities encompass investigating new ideas or technologies and using the results to build or improve goods or processes through design, testing, and refining. The objectives of continuous innovation force businesses to engage in R&D to create new products, improve old ones, and remain competitive by satisfying changing consumer needs. Ready-to-use LB liquid medium is an important component in R&D because it promotes bacterial growth, gene cloning, protein expression, and other genetic modifications. Its convenience and dependability make it essential for a variety of experimental techniques and large-scale research applications. For instance, in September 2025, according to the National Science Foundation (NSF), a U.S.-based government agency, businesses continued to increase their research and development (R&D) performance in 2023, spending $722 billion on R&D in the United States, a 4.4% increase from 2022. Therefore, increasing research and development activities drive the ready-to-use Luria-Bertani (LB) liquid medium industry. The rising number of clinical trials is expected to propel the growth of the ready-to-use Luria-Bertani (LB) liquid medium market going forward. A clinical trial is a research study involving human participants to assess the safety and effectiveness of a new medical intervention before it is approved for general use. The surge in clinical trials is driven by the demand for personalized medicine, which aims to create treatments customized for individual genetic profiles and specific health conditions. Clinical trials demand consistent conditions for accurate results, and ready-to-use LB liquid medium ensures this reliability without the need for preparation or sterilization. This efficiency speeds up the research process, particularly in high-throughput and multi-site studies. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based nonprofit organization, the number of industry-initiated clinical trials in the UK grew from 411 trials in 2022 to 426 trials in 2023, marking a 3.7% increase. Therefore, the rising number of clinical trials drives the ready-to-use Luria-Bertani (LB) liquid medium industry.Key Players In The Global Ready-To-Use Luria-Bertani (LB) Liquid Medium Market
Major companies operating in the ready-to-use luria-bertani (lb) liquid medium market are Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, Hardy Diagnostics Inc., MP Biomedicals LLC, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech LdaGlobal Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Trends and Insights
Major companies operating in the ready-to-use Luria-Bertani (LB) liquid medium market are focusing on advancements in drug discovery software to gain a competitive edge. For instance, in December 2023, Merck, a Germany-based pharmaceuticals and biotechnology products company, launched AIDDISON, a cutting-edge drug discovery software that utilizes artificial intelligence and machine learning algorithms to accelerate the identification of potential drug candidates. AIDDISON features a user-friendly interface and advanced data analysis capabilities, allowing researchers to efficiently process and interpret large volumes of data. This innovative software has the potential to revolutionize the drug discovery process, ultimately leading to faster and more cost-effective development of new therapeutics.Regional Outlook
Europe was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Ready-To-Use Luria-Bertani (LB) Liquid Medium Market?
The ready-to-use Luria-Bertani (LB) liquid medium market consists of sales of bacterial growth medium, cell culture medium, transformation medium, and research medium. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report 2026?
The ready-to-use luria-bertani (lb) liquid medium market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ready-to-use luria-bertani (lb) liquid medium industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Ready-To-Use Luria-Bertani (LB) Liquid Medium Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $12.16 billion |
| Revenue Forecast In 2035 | $16.63 billion |
| Growth Rate | CAGR of 8.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, Hardy Diagnostics Inc., MP Biomedicals LLC, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech Lda |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Ready-To-Use Luria-Bertani (LB) Liquid Medium market was valued at $11.21 billion in 2025, increased to $12.16 billion in 2026, and is projected to reach $16.63 billion by 2030.
request a sample hereThe global Ready-To-Use Luria-Bertani (LB) Liquid Medium market is expected to grow at a CAGR of 8.1% from 2026 to 2035 to reach $16.63 billion by 2035.
request a sample hereSome Key Players in the Ready-To-Use Luria-Bertani (LB) Liquid Medium market Include, Thermo Fisher Scientific Inc., Avantor Inc., Lonza Group AG, Sigma Aldrich Chemicals Pvt. Ltd., Bio-Rad Laboratories Inc., Neogen Corporation, Hardy Diagnostics Inc., MP Biomedicals LLC, Alpha Teknova Inc., HiMedia Laboratories Pvt. Ltd., Scharlab S.L., Interchim, Condalab, Quality Biological Inc., Thomas Scientific LLC, Geno Technology Inc., Central Drug House (P) Ltd., Citotest Labware Manufacturing Co. Ltd., Research Products International, NZYTech Lda .
request a sample hereMajor trend in this market includes: Advancements in Drug Discovery Software. For further insights on this market.
request a sample hereEurope was the largest region in the ready-to-use Luria-Bertani (LB) liquid medium market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ready-to-use luria-bertani (lb) liquid medium market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here